The ethics of gene editing, particularly with technologies like **CRISPR**, raise important questions about the potential benefits and risks. Gene editing offers the promise of curing genetic diseases, improving human health, and preventing inherited disorders. However, ethical concerns arise around **designer babies**, where gene editing could be used to enhance traits like intelligence or physical appearance, leading to social inequality and discrimination. There are also concerns about unintended consequences, such as off-target effects or long-term impacts on the human gene pool. Balancing the potential medical benefits with the ethical risks requires careful regulation, public dialogue, and adherence to ethical guidelines.